Literature DB >> 9467564

The insulin-like growth factor axis and plasma lipid levels in the elderly.

G P Ceda1, E Dall'Aglio, A Magnacavallo, N Vargas, V Fontana, M Maggio, G Valenti, P D Lee, R L Hintz, A R Hoffman.   

Abstract

The activity of the hypothalamic-GH-insulin-like growth factor (IGF) network declines with age. It has recently been shown that increased cardiovascular mortality occurs in adults with GH deficiency. As hypercholesterolemia is common in GH-deficient adults, and because there is experimental evidence that GH may play a role in regulating plasma cholesterol, we decided to investigate the activity of the GH-IGF axis in an elderly population by measuring serum IGF-I, IGF-II, and IGF-binding protein-3 (IGFBP-3) levels and to study their relationship with blood lipid levels. One hundred and thirty-two elderly subjects, 52 men and 80 women, were studied (age range, 60-91 yr). Men had significantly lower levels of IGFBP-3, high density lipoprotein cholesterol (HDL-C) and apoprotein A1 (ApoA1) compared to the women, whereas IGF-I and IGF-II were only slightly lower. Using linear regression analysis, we observed an inverse relationship of age with IGF-I (r = -0.35; P < 0.001), IGF-II (r = 0.40; P < 0.001), IGFBP-3 (r = 0.52; P < 0.001), body mass index, and lipid levels. Univariate regression analysis showed a strong and positive correlation of both IGF-I and IGFBP-3 with HDL-C and ApoA1. Partial correlation analysis, after adjustment for age and body mass index, showed that IGFBP-3 and IGF-II were still significantly and positively related to HDL-C and ApoA1. Furthermore, a strong association was documented among IGF-I, IGF-II, and IGFBP-3. These data demonstrate that even in an elderly population, further aging is accompanied by a progressive decline in circulating IGF-I, IGF-II, and IGFBP-3, suggesting a continuing diminution of the GH-IGF axis throughout aging. Moreover, the strong correlation between HDL-C and an index of GH secretion, such as IGFBP-3, suggests that GH might play an important role in lipid metabolism in healthy elderly subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467564     DOI: 10.1210/jcem.83.2.4548

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 2.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community.

Authors:  Carolyn S P Lam; Ming-Huei Chen; Sean M Lacey; Qiong Yang; Lisa M Sullivan; Vanessa Xanthakis; Radwan Safa; Holly M Smith; Xuyang Peng; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-08       Impact factor: 8.311

4.  Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shari M Ling; E Jeffrey Metter; Andrea Artoni; Laura Carassale; Anna Cazzato; Graziano Ceresini; Jack M Guralnik; Shehzad Basaria; Giorgio Valenti; Luigi Ferrucci
Journal:  Arch Intern Med       Date:  2007-11-12

5.  Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.

Authors:  Eileen Hsu; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

6.  Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats.

Authors:  Inma Castilla-Cortázar; María García-Fernández; Gloria Delgado; Juan E Puche; Inma Sierra; Rima Barhoum; Salvador González-Barón
Journal:  J Transl Med       Date:  2011-07-06       Impact factor: 5.531

7.  An IGF-I promoter polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36.

Authors:  Saskia J te Velde; Elisabeth F C van Rossum; Paul G Voorhoeve; Jos W R Twisk; Henriette A Delemarre van de Waal; Coen D A Stehouwer; Willem van Mechelen; Steven W J Lamberts; Han C G Kemper
Journal:  BMC Endocr Disord       Date:  2005-06-01       Impact factor: 2.763

8.  Placental structure in type 1 diabetes: relation to fetal insulin, leptin, and IGF-I.

Authors:  Scott M Nelson; Philip M Coan; Graham J Burton; Robert S Lindsay
Journal:  Diabetes       Date:  2009-08-18       Impact factor: 9.461

9.  Insulin-Like Growth Factor-II and Ischemic Stroke-A Prospective Observational Study.

Authors:  Daniel Åberg; N David Åberg; Katarina Jood; Petra Redfors; Christian Blomstrand; Jörgen Isgaard; Christina Jern; Johan Svensson
Journal:  Life (Basel)       Date:  2021-05-29

10.  Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.

Authors:  Shuang Liang; Yanyan Hu; Caihong Liu; Jianhong Qi; Guimei Li
Journal:  Lipids Health Dis       Date:  2016-06-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.